Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) EBITDA (2023 - 2025)

Historic EBITDA for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $16.4 million.

  • Guardian Pharmacy Services' EBITDA rose 11563.29% to $16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 19149.35%. This contributed to the annual value of -$62.9 million for FY2024, which is 25366.58% down from last year.
  • Guardian Pharmacy Services' EBITDA amounted to $16.4 million in Q3 2025, which was up 11563.29% from $12.6 million recorded in Q2 2025.
  • Guardian Pharmacy Services' 5-year EBITDA high stood at $17.0 million for Q2 2024, and its period low was -$104.6 million during Q3 2024.
  • For the 3-year period, Guardian Pharmacy Services' EBITDA averaged around -$1.3 million, with its median value being $13.0 million (2025).
  • In the last 5 years, Guardian Pharmacy Services' EBITDA plummeted by 155265.4% in 2024 and then soared by 11563.29% in 2025.
  • Quarter analysis of 3 years shows Guardian Pharmacy Services' EBITDA stood at $15.5 million in 2023, then rose by 7.93% to $16.8 million in 2024, then decreased by 2.39% to $16.4 million in 2025.
  • Its EBITDA was $16.4 million in Q3 2025, compared to $12.6 million in Q2 2025 and $13.0 million in Q1 2025.